Protective role of antioxidant vitamin E and catechin on doxorubicin-induced cardiotoxicity in rats

Cancer Research, Therapy and Control

Volumn 11, Issue 2, 2001, Pages 175-182

  Kalender, Suna ^a   Kavutcu, Mustafa ^b   Kalender, Yusuf ^b   Olcay, Ekmel ^c   Yel, Mustafa ^b   Ateş, Ahmet ^c  

^a ANKARA UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c Refik Saydam Zent Inst Hyg   (Turkey)

Author keywords

Cardiotoxicity; Catechin; Doxorubicin; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CATALASE; CATECHIN; DOXORUBICIN; FREE RADICAL; GLUTATHIONE PEROXIDASE; IRON CHELATING AGENT; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CARDIOTOXICITY; CONTROLLED STUDY; DOSE RESPONSE; ELECTROCARDIOGRAM; ELECTRON MICROSCOPY; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; LETHAL DOSE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034951175     PISSN: 10640525     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Alderton P.M., Gross J. and Green, M.D. (1992). Comparative study of doxorubicin, mitoxantrone and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model. Cancer Res., 52, 194-201.
2. Alderton P., Gross J. and Green M.D. (1990). Role of (+)-1,2-bis (3,5-dioxopiperazinyl-1-yl) propana (ICRF-187) in modulating free radical scavenging enzymes in doxorubicin-induced cardiomyopathy. Cancer Res., 50, 5136-5142.
3. Bors W., Heller W., Michel C. and Saran M. (1990). Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol., 186, 343-355.
4. Bristow M.R., Minobe W.A., Billingham M.E., Marmor J.B., Johnson G.A., Ishimoto B.M., Sageman S. and Daniels J.R. (1981a). Anthracycline-associated cardiac and renal damage in rabbits. Am Heart J., 45, 157-168.
5. Bristow M.R., Mason J.W., Billingham M.E. and Daniels J.R. (1981b). Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Lab. Invest., 102, 709-718.
6. Dodd D.A., Atkinson J.B., Olson R.D., Buck S., Cusack B.J., Fleischer S. and Boucek Jr R.J. (1993). Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model. Invest., 91, 1697-1705.
7. Doroshow J.S. (1983) Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide and hydroxyl radical production by NADH dehydrogenase. Cancer Res., 43, 4543-4551.
8. Durak İ., Öztürk H.S., Kavutcu M., Birey M., Yel M., Güven T., Olcay E., Kaçmaz M. and Canbolat O. (1998). Protective role of antioxidant vitamins on adriamycin-induced free radical production and cardiotoxicity in guinea pigs. Cancer Res. Ther. Cont., 5, 133-141.
9. Herman E.H. and Ferrans V.J. (1987) Amelioration of chronic anthracyclines cardiotoxicity by ICRF-187 and other compounds. Cancer Treat. Rev., 14, 225-229.
10. Hodnick W.F., Kung F.S., Roettger W.J., Bohmont C.W. and Pardini R.S. (1986). Inhibition of mitochondrial respiration and production of toxic oxygen radicals by flavonoids. Biochem. Pharmacol., 35, 2345-2357.
11. Kavutcu M., Canbolat O., Öztürk S., Olcay E., Ulutepe S., Ekinci C., Gökhun I.A. and Durak I. (1996). Reduced enzymatic anti-oxidant defense mechanism in kidney tissues from gentamicin-treated guines pigs: effect of vitamins E and C. Nephron 72, 269-274.
12. Kozluca O., Olcay E., Sürücü S., Güran Z., Kulaksiz T. and Üskent N. (1995). Prevention of doxorubicin induced cardiotoxicity by catechin. Cancer Lett., 98, 1-6.
13. Lee V., Randhawa A.K. and Singal P.K. (1991). Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am J. Physiol., 261, 989-995.
14. Lowry O.H., Rosebrough N.J., Farr A.L. and Randall R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 183, 265-275.
15. Milei J., Boveris A., Llesuy S., Molina H.A., Storino R., Ortega D. and Milei S.E. (1986). Amelioration of adriamycin-induced cardiotoxicity in rabbits by prenylamine and vitamins A and E. Am Heart J., 111, 95-102.
16. Milner L.S., Wei S.H., Stohs S.J., Eldeen Z.M. and Houser M.T. (1992). Role of glutathione metabolism in the reduction of proteinuria by dimethylthiourea in adriamycin nephrosis. Nephrosis, 62, 192-197.
17. Mimnaugh E.G., Gram T.E. and Trush M.A. (1983). Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers. J. Pharmacol. Exp. Ther., 226, 806-816.
18. Mimnaugh E.G., Kenedy K.A., Trush M.T. and Sinha B.K. (1985). Adriamycin enhanced membrane lipid peroxidation in isolated rat nuclei. Cancer Res., 45, 3296-3304.
19. Myers C.E., McGuire W.P., Liss R.H., Ifrim I., Grotzinger K. and Young R.C. (1977). Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 197, 165-167.
20. Myers C.E., Gianni L., Simone C.B., Kleker R. and Green R. (1982). Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complexes. Biochemistry, 21, 1707-1713.
21. Paglia D.E. and Valentine W.N. (1967). Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 70, 158-169.
22. Rajagopalan S., Politi P.M., Sinha K. and Myers C.E. (1988). Adriamycin-induced free radical formation in the perfused rat heart: Implications for cardiotoxicity. Cancer Res., 48, 4766-4769.
23. Sinha B.K. (1982). Cardiotoxicity of anthracyclines and other anti-tumor drugs, in Cardiovascular Toxicology (Van Stee EW. ed) pp181-197, Raven Press, New York.
24. Sonneveld P. (1978). Effect of α-tocopherol on the cardiotoxicity of adriamycin in the rat. Cancer Treat. Rep., 62, 1033-1036.
25. Thompson J.A. and Hess M.L. (1986). The oxygen free radical system: A fundamental mechanism in the production of myocardial necrosis. Prog. Cardiovasc. Dis., 28, 449-462.
26. Torti F.M., Bristow M.R., Howes A.E., Aston D., Stockdale F.E., Carter S.K., Kohler M., Brown B.W. and Billingham M.E. (1983). Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Ann. Intern. Med., 99, 745-749.
27. Van Vleet J.F., Greenwood L., Ferrans V.J. and Rebar A.M. (1978). Effect of selenium-vitamin E on adriamycin-induced cardiomyopathy in rabbits. Am J. Vet. Res., 39, 997-1010.
28. Van Ye T.M., Roza A.M., Pieper G.M., Henderson Jr J., Johnson C.P. and Adams M.B. (1993). Inhibition of intestinal lipid peroxidation does not minimize morphological damage. J. Surg. Res., 55, 553-558.
29. Villani F., Galimberti M. and Comazzi R. (1991). Early cardiac toxicity of 4′-iodo-4′-deoxydoxorubicin. Eur. J. Cancer, 27, 1601-1604.
30. Wakasugi S., Fischman A.J., Babich J.W., Callahan R.J., Elmaleh D.R., Wilkinson R. and Strauss W. (1993). Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy. J. Nucl. Med., 34, 1529-1535.
31. Wang C. (1981). Pharmacokinetics in Pharmacology, Lippincott Academic Press. New York pp. 671-681.
32. Wang Y.M., Madanat F.F., Kimball J.C., Gleiser C.A., Ali M.K., Kaufman M.W. and van Eys J. (1980). Effect of vitamin E against adriamycin-induced toxicity in rabbits. Cancer Res., 40, 1022-1027.